Business
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference InM...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nInMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference\nCanada NewsWire\nVANCOUVER, Feb. 9, 2017\n\n\n\nCSE: INOTCQB: IMLFF \n\n\n\nVANCOUVER, Feb. 9, 2017 /CNW/ - InMed Pharmaceuticals, Inc. (\"InMed\") (CSE: IN; OTCQB: IMLFF), announced today that Eric A. Adams, Chief Executive Officer, will provide a corporate overview and business update at the 2017 BIO-CEO & Investor Conference, being held on February 13th-14th, 2017 at the Waldorf Astoria, New York City.\n\n\n \n \n\n \nBIO CEO & Investor Conference - InMed Presentation Details\n\nDate:        Tuesday, February 14th   Time:        2:30 Eastern TimeLocation:  The Waldorf Astoria, New York, New York Room:       Park South\n\nAbout BIO \n\nBIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. The 19th Annual BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Each year the conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.\n\nAbout InMed \n\nInMed is a pre-clinical stage biopharmaceutical company that specializes in de...